PEX4 Antibody

What is PEX4 and what cellular functions does it perform?

PEX4 is a peroxisomal biogenesis factor that functions as an E2 ubiquitin-conjugating enzyme in the ubiquitination process. It plays an essential role in protein transport to peroxisomes by facilitating the recycling of peroxisomal import receptors. PEX4 possesses sequence similarity to ubiquitin-conjugating (UBC) proteins, particularly in regions surrounding the putative active-site cysteine residue that forms thioester bonds with ubiquitin . Defects in PEX4 function can lead to abnormal accumulation of peroxisomal receptors like PEX5 at peroxisomal membranes, disrupting normal peroxisomal protein import . In plants such as Arabidopsis, mutations in PEX4 (as seen in apem7 mutants) interfere with efficient protein transport to peroxisomes, highlighting its conserved importance across species .

What is the subcellular localization of PEX4 and how can this be verified experimentally?

PEX4 is exclusively localized on peroxisomal membranes. This localization has been experimentally verified through:

• Subcellular fractionation: When total proteins are separated into soluble and membrane fractions, PEX4 is detected exclusively in the membrane fraction .

• Immunoelectron microscopy: Using gold particle-labeled antibodies against PEX4 (15 nm particles) and peroxisomal markers like catalase (10 nm particles), PEX4 has been visualized specifically at the peroxisomal membrane .

Interestingly, PEX4 lacks transmembrane domains or distinct membrane-binding motifs but associates with the peroxisomal membrane through binding to the membrane protein PEX22 . For researchers wanting to verify PEX4 localization, immunofluorescence microscopy using PEX14 (a known peroxisomal membrane marker) as a co-stain is recommended for colocalization studies .

What is the expected molecular weight of PEX4 in Western blot applications?

When performing Western blot analysis for PEX4, researchers should expect to observe:

• An 18 kDa band corresponding to the unmodified PEX4 protein under reducing conditions

• A 28 kDa band corresponding to ubiquitinated PEX4 under non-reducing conditions

The difference in molecular weight between these two forms (~10 kDa) is consistent with the addition of a single ubiquitin moiety. Notably, in certain mutants like the apem7 mutant, the 28 kDa ubiquitinated form may be present even under reducing conditions, although at decreased levels . When designing Western blot experiments, researchers should use appropriate reducing agents (e.g., DTT or β-mercaptoethanol) to distinguish between these forms and gain insights into PEX4's ubiquitination state.

What applications are validated for commercially available PEX4 antibodies?

Commercial PEX4 antibodies have been validated for multiple research applications:

When selecting a PEX4 antibody, researchers should consider the specific application needed and verify the antibody has been validated for that particular use with relevant positive controls .

What species reactivity should researchers expect from PEX4 antibodies?

Commercial PEX4 antibodies show documented reactivity with multiple species:

This broad cross-reactivity indicates conservation of PEX4 epitopes across diverse species . When working with non-validated species, researchers should perform preliminary validation experiments including positive and negative controls. Western blot analysis showing bands at the expected molecular weight (18 kDa unmodified, 28 kDa ubiquitinated) is recommended as an initial validation step.

How does the ubiquitination state of PEX4 affect peroxisomal protein transport?

The ubiquitination state of PEX4 directly impacts its function in peroxisomal protein transport through several mechanisms:

• Active E2 enzyme formation: Ubiquitination of PEX4 at its active site cysteine (C90 in Arabidopsis) is essential for its function as an E2 enzyme. Site-directed mutagenesis replacing this cysteine with alanine (C90A) renders PEX4 inactive .

• Receptor recycling regulation: Properly ubiquitinated PEX4 facilitates the recycling of peroxisomal import receptors like PEX5 from the peroxisomal membrane back to the cytosol. In mutants with disrupted PEX4 ubiquitination (e.g., apem7), abnormal accumulation of PEX5 at the peroxisomal membrane occurs .

• Modified PEX5 processing: The membrane-associated PEX5 shows a slightly larger molecular size than cytosolic PEX5, suggesting post-translational modification, potentially ubiquitination. This modified form increases in apem7 mutants, indicating PEX4's involvement in PEX5 processing .

Experimentally, researchers can use non-reducing versus reducing SDS-PAGE conditions to assess the ubiquitination state of PEX4. The appearance of the 28 kDa band under non-reducing conditions indicates functional ubiquitination, while its persistence under reducing conditions in mutants suggests abnormal ubiquitination dynamics .

What experimental approaches are recommended for studying PEX4-dependent ubiquitination?

Studying PEX4-dependent ubiquitination presents several challenges, primarily related to protein solubility. Several approaches can be employed:

• In vivo ubiquitination analysis:

  • Compare ubiquitination patterns under reducing vs. non-reducing conditions using SDS-PAGE

  • Look for the characteristic 10 kDa shift in molecular weight (18 kDa → 28 kDa) indicating ubiquitinated PEX4

  • Use ubiquitin-specific antibodies in co-immunoprecipitation experiments

• Genetic approaches:

  • Generate site-directed mutations of key residues (e.g., active site C90A in Arabidopsis)

  • Create knockout/knockdown models and perform rescue experiments with wild-type or mutant PEX4

• Expression system optimization:

  • Traditional E. coli expression systems have yielded insoluble PEX4, making in vitro assays challenging

  • Consider alternative expression systems:

    • Insect cell expression

    • Cell-free systems

    • Fusion tags that enhance solubility (MBP, SUMO, etc.)

• Suborganellar fractionation:

  • Separate peroxisomal membranes from matrix to analyze PEX4 association

  • Compare ubiquitination patterns across fractions

When designing such experiments, researchers should note that standard in vitro ubiquitination assays have been unsuccessful due to PEX4 insolubility issues, as reported by multiple research groups .

What controls are essential when validating PEX4 antibodies for research applications?

Rigorous validation of PEX4 antibodies requires several controls:

• Positive controls:

  • Transfected cells overexpressing PEX4

  • Tissues with known high expression (based on public databases)

  • Purified recombinant PEX4 protein (for Western blot)

• Negative controls:

  • PEX4 knockout/knockdown samples

  • Pre-immune serum (for polyclonal antibodies)

  • Isotype control (for monoclonal antibodies)

  • Peptide competition assay using the immunizing peptide

• Application-specific controls:

  • For Western blot: Molecular weight markers to confirm the 18 kDa band (unmodified) and 28 kDa band (ubiquitinated)

  • For immunofluorescence: Co-staining with established peroxisomal markers like PEX14

  • For immunohistochemistry: Omitting primary antibody while maintaining secondary antibody

• Cross-reactivity assessment:

  • Testing against related UBC family proteins

  • Testing in multiple species if cross-species reactivity is claimed

Reporting antibody validation data according to standards such as those proposed by the International Working Group for Antibody Validation (IWGAV) increases experimental reproducibility.

How can researchers troubleshoot non-specific binding when using PEX4 antibodies?

Non-specific binding is a common challenge when working with antibodies. For PEX4 antibodies specifically:

• Optimize blocking conditions:

  • Test different blocking agents (BSA, non-fat milk, commercial blockers)

  • Increase blocking time or blocker concentration

  • Consider adding 0.1-0.5% Triton X-100 to reduce hydrophobic interactions

• Antibody dilution optimization:

  • Perform titration experiments (typically starting with 1:500-1:2000 for Western blot)

  • Higher dilutions often reduce background while maintaining specific signal

• Address common non-specific bands:

  • 28 kDa bands under reducing conditions may represent incompletely reduced PEX4-ubiquitin conjugates

  • Additional bands around 50-60 kDa might represent interactions with other peroxisomal proteins

• Sample preparation refinements:

  • For membrane proteins like PEX4, optimize lysis buffers (consider NP-40 or Triton X-100)

  • Include protease inhibitors to prevent degradation

  • For ubiquitinated proteins, add deubiquitinase inhibitors (N-ethylmaleimide)

• Alternative detection methods:

  • For Western blots, consider fluorescent secondary antibodies which can provide cleaner backgrounds than HRP-based detection

  • For immunofluorescence, try different fixation methods (4% paraformaldehyde is standard, but methanol may work better for certain epitopes)

What are the best experimental approaches for studying PEX4 interactions with other peroxisomal proteins?

Investigating PEX4 interactions with other peroxisomal proteins requires specialized approaches:

• Co-immunoprecipitation (Co-IP):

  • Use anti-PEX4 antibodies to pull down protein complexes

  • Analyze by Western blot for known interactors (PEX5, PEX22)

  • Consider crosslinking to stabilize transient interactions

• Proximity labeling techniques:

  • BioID or APEX2 fusions to PEX4 to identify proximal proteins

  • TurboID for faster labeling kinetics

  • These methods are particularly valuable for membrane protein interactions

• Fluorescence microscopy approaches:

  • Fluorescence resonance energy transfer (FRET)

  • Bimolecular fluorescence complementation (BiFC)

  • These can provide spatial information about interactions at the peroxisomal membrane

• Genetic interaction studies:

  • Create double mutants (e.g., pex4/pex5) to assess epistatic relationships

  • Rescue experiments with mutant constructs (e.g., PEX4-C90A)

• In vitro binding assays:

  • GST pull-down or His-tag pull-down using fragments of PEX4

  • Surface plasmon resonance (SPR) for quantitative binding kinetics

When studying ubiquitination-dependent interactions, researchers should consider using proteasome inhibitors (MG132) and deubiquitinase inhibitors to stabilize ubiquitinated intermediates. Additionally, analysis under both reducing and non-reducing conditions can provide insights into thioester-linked interactions involving the active site cysteine of PEX4 .